We compared pulse wave velocity (PWV) between hypertensive patients and control patients to identify demographics and patient characteristics related to PWV. We retrospectively analyzed 9923 participants (3105 controls and 6818 hypertensive patients) from 5 outpatient hypertensive clinics (in Serbia and Greece). Pulse wave velocity had different distribution between controls and hypertensive patients (P < .001). The magnitude of PWV increase was related to blood pressure (BP) category (from optimal to stage III hypertension; P < .001). Even in hypertensive patients with systolic BP (SBP) <140 and/or diastolic BP (DBP) <90 mm Hg, PWV was greater than in control patients (P < .001). Pulse wave velocity was associated with almost all baseline characteristics of hypertensive patients (body mass index [BMI], gender, age, SBP, DBP, smoking status, and heart rate; P < .001). This association remained after adjustment of PWV confounders. There were 2231 (32.7%) hypertensive patients who had reached SBP <140 mm Hg and DBP <90 mm Hg. Pulse wave velocity was increased in hypertensive patients, and the degree of PWV increase was associated with baseline BP as well as with anthropometric parameters (eg, BMI, gender, age, heart rate, and smoking status).
Introduction
Total cardiovascular (CV) risk assessment is necessary in order to maximize a cost-effective management of hypertension according to current guidelines. 1 Arterial stiffness represents an established risk factor with significant prognostic ability for future events, 1, 2 and pulse wave velocity (PWV) measurement represents the gold standard for aortic stiffness assessment.
The additive value of PWV beyond traditional risk factors, including Systemic Coronary Risk Evaluation (SCORE) and Framingham risk score, has been quantified in several studies. 3, 4 Thus, arterial stiffness, as assessed by PWV measurement, permits organ damage assessment and is recommended by current guidelines to assess CV risk in hypertensive patients. The aim of the present study was to compare PWV between hypertensive patients and controls and to identify demographics and characteristics related to PWV.
Methods
We retrospectively enrolled 9923 patients (3105 controls and 6818 hypertensive patients) from 5 outpatient hypertension clinics in Serbia and Greece. The study protocol was approved by the ethics committee of the respective hospitals. Individuals were included in the study if they satisfied the following criteria:
Healthy patients (controls) >18 years old. Hypertensive patients >18 years old. In sinus rhythm. Stable clinical condition.
Individuals were excluded from the study if they:
were hospitalized for CV disease during the 3 last months, had medical conditions, which according to the investigator's judgment could exclude the patient participation in the study, such as severe end-stage diseases or severe neuropsychiatric diseases, had chronic atrial fibrillation, and were pregnant.
The following parameters were assessed in all patients: gender, age, height, weight, body mass index (BMI), heart rate (HR) at rest, systolic blood pressure (SBP) and diastolic blood pressure (DBP), smoking status, antihypertensive treatment, and PWV measurement. Blood pressure (BP) was measured 3 times with 1-minute intervals according to the European Society of Hypertension/Cardiology guidelines. 1, 5 A validated automated oscillometric device was used for all measurements with a medium-or a large-size cuff, according to the participant's arm circumference.
Arterial Stiffness Assessment
Arterial stiffness was assessed by Arteriograph (TensioMed, Budapest, Hungary). This device determines PWV by Fourier analysis of the oscillometric pressure curves registered in the upper arm. Briefly, during systole, the ejected volume into the aorta generates a pulse wave called "early systolic peak." This wave is propagated into the periphery and at the level of aortic bifurcation is reflected backward generating a second wave "late systolic peak." The difference between the early and late systolic peak (in milliseconds) represents the return time of the wave. The aortic PWV is calculated from the return time and the distance traveled by the pulse wave (distance between the sternal notch and the pubic symphysis). This device has been used for this purpose in several studies. [6] [7] [8] [9] [10] Statistical Analysis Descriptive statistics. Continuous variables (eg, age) were presented using the mean and standard deviation (SD). Categorical variables (eg, gender) were presented using tables of frequencies.
Statistical inference. We used the t test to compare age, BMI, SBP, DBP, and HR between hypertensives and controls. We used the w 2 test to compare the distribution of gender and smoking status between hypertensives and controls. Multiple linear regression (stepwise selection) tested the relation of PWV with the following, independent, parameters: (1) gender (0 ¼ female, 1 ¼ male), (2) age, (3) BMI, (4) SBP, (5) DBP, (6) HR, (7) smoking (1 ¼ yes, 0 ¼ no), (8) (9) interaction between group and SBP, and (10) interaction between group and DBP. The technique was applied on the total sample. For hypertensives and controls separately, multiple linear regression (stepwise selection) tested the relation of PWV with the following, independent, parameters: (1) gender (0 ¼ female, 1 ¼ male), (2) age, (3) BMI, (4) SBP, (5) DBP, (6) HR, and (7) smoking (1 ¼ yes, 0 ¼ no). As far as hypertensives patients and antihypertensive medications are concerned, medications were expected to have confounding effects with the main explanatory variables (SBP and DBP). Since this is a retrospective study, and the medications were prescribed by the physicians because the patients had an elevated BP, the effects of both BP and the medication on PWV could not be adequately separated and estimated via a typical regression model, which includes all the variables. The dependent variable of this model was PWV, while the independent ones were (1) 
Results
The analysis included 9923 patients (controls: 3105; hypertensives: 6818); 61.0% of the patients were female; the sample's mean age was 58.3 (12.0) years, while the mean BMI was 28.0 (4.9) kg/m 2 . The mean SBP was 139.7 (21.6) mm Hg, while the mean DBP was 83.3 (11.7) mm Hg. Most of the patients (6837 patients /68.9% of the sample) were nonsmokers. Smokers were more frequent in the control group (Pearson w 2 statistic P < .001). Only 2231 (32.7%) hypertensive patients had SBP <140 mm Hg and DBP <90 mm Hg. Patient's baseline characteristics are shown in Table 1 .
Effect of BMI, Age, Systolic BP, Diastolic BP, Smoking, and HR on PWV Among Hypertensive and Control Patients Systolic BP, DBP, age, BMI, and HR were positively correlated with PWV (in the case of age, HR, SBP, and DBP, linear regression t-statistic was P < .001, while the linear regression tstatistic in the case of BMI was P ¼ .025; Tables 2 and 3) .
Pulse wave velocity was higher in smokers and in hypertensive patients (linear regression t-statistic P < 0.001 in both cases). For hypertensives and controls separately, multiple linear regression (stepwise selection) tested the relation of PWV with the following independent parameters: (1) gender (0 ¼ female, 1 ¼ male), (2) age, (3) BMI, (4) SBP, (5) DBP, (6) HR, and (7) smoking (1 ¼ yes, 0 ¼ no). The results were almost identical ( Table 2) . Systolic BP, DBP, age, BMI, and HR were positively correlated with PWV in hypertensive and control patients, with the exception of BMI in hypertensive patients (P ¼ nonsignificant) where the stratification of the hypertensive patients with respect to their "BMI group" had no significant statistical differences in PWV. The distribution of PWV across age, BMI classification, and BP classification is shown in Table 3 . The antihypertensive medications were not included in the regression models because of the confounding effect they have on the main variables (SBP and DBP).
Discussion
To the best of our knowledge, this is the largest study that compared PWV between hypertensive patients and control patients, as well as demographics and individual characteristics related to PWV.
The results of this retrospective study confirm older studies which suggested that characteristics such as BMI, age, gender, BP, and HR are strongly associated with PWV. [11] [12] [13] [14] Although the results of the study are not novel, the large sample (9923 participants) strengthens the results. In addition, smoking status was significantly associated with PWV. It is well known that smoking adversely affects arterial elastic properties inducing endothelial dysfunction, vascular inflammation, and damage to the extracellular matrix [15] [16] [17] conditions that increase arterial stiffness and PWV. 15 In addition to all these chronic alterations, tobacco smoking induces an acute increase in arterial stiffness and PWV as well as BP and HR, probably because of the activation of sympathetic system induced by nicotine, as well as endothelial dysfunction. 18 Unfortunately, in this study, the effect of drugs on PWV could not be assessed. Since this was a retrospective study, and the medications were prescribed by the physicians because the patients had arterial hypertension, the effects of both BP and the medication on the dependent variable could not be adequately separated and estimated via a regression model. In addition, the duration of antihypertensive administration was unknown. It is well known that the presence of arterial hypertension increases arterial stiffness and PWV. In this study, hypertensive patients with controlled BP (<140 and/or 90 mm Hg) also showed higher PWV than controls. This fact underlines the deleterious effect of arterial hypertension per se, increasing arterial stiffness, although there are no long-term follow-up data to assess the effect of various drugs in hypertensive patients with controlled BP. Antihypertensive drugs may affect PWV not only because they decrease BP but also because they may positively affect endothelial function. Arterial stiffness can be affected by both structural and functional changes in the artery. Hence, we cannot attribute the PWV decrease solely to BP decrease. Antihypertensive drug classes also exert other properties contributing to structural de-stiffening of the arteries, within a few months changing the arterial geometry and structure, reducing the degree of fibrosis while increasing elastin/collagen ratio, and influencing remodeling of the arterial wall. 19, 20 Of note, in this study, HR represented another statistically significant parameter influencing PWV. Increased HR is associated with increased PWV. Several epidemiological studies showed a significant and independent association between HR and PWV. 11, 21, 22 In animal models, atrial pacing decreases arterial distensibility in parallel with increased HR. 23 The significant correlation of HR with PWV in healthy and hypertensive patients may raise methodological concerns on PWV measurement, leading to a further assessment of this association with randomized controlled studies in order to determine its relationship and the possible need for a standardized PWV for HR.
In our study, the stratification of the hypertensive patients with respect to their "BMI group" had no significant statistical differences in PWV in hypertensive patients, although there are several studies correlating PWV with BMI. 24, 25 In accordance with our study, no significant correlation between BMI and PWV was revealed in a recent prospective study of 29 morbidly obese patients. 26 Moreover, there are studies affirming the opposite where BMI and body fat were shown to be negatively associated with PWV. 27 These discrepancies might have several explanations, including the low percentage of obese participants, the low number of participants in the study, as well as the effect of various drugs on PWV. Additionally, the percentage of females may have influenced these results since there are studies affirming that BMI, waist circumference, waist-to-hip ratio, visceral fat area, and fat mass were independently associated with higher PWV in women, but not in men, after adjustment for age, hypertension, and type 2 diabetes. 24 The percentage of class II and III obese patients was low in our study (7.4/2.5% in hypertensive patients and 2.7/0.7% in healthy control patients); the sample size of the study may represent BMI distribution in the Balkans.
Although retrospective, this study provides interesting epidemiologic insight. To the best of our knowledge, this is the first regional study (in the Balkan area) that assessed arterial stiffness through PWV measurement in healthy patients and hypertensive patients. The finding that only 2231 (32.7%) hypertensive patients had SBP <140 mm Hg and DBP <90 mm Hg is in accordance with previous studies assessing the control of BP in Serbia and Greece (27.7% in Serbia 28 and 34% in Greece 29 ). This is a retrospective study and hence susceptible to patient and treatment selection bias. In addition, data from a single patient visit were included. Hence, changes in BP and PWV as well as other patient characteristics over time are not available. In addition, no homogeneous data regarding other risk factors such as diabetes mellitus and hyperlipidemia were available.
Pulse wave velocity is increased in hypertensive patients. The degree of PWV increase is associated with baseline BP and HR as well as with anthropometric parameters such as BMI, gender, age, and smoking status.
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